TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
0.370
+0.034 (10.02%)
Nov 21, 2024, 12:07 PM EST - Market open
TransCode Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 6 | 4 | 9 | 33 | - | - | |
| Market Cap Growth | 576.11% | -52.64% | -73.32% | - | - | - | |
| Enterprise Value | 4 | -3 | -0 | 10 | - | - | |
| Last Close Price | 0.34 | 6.59 | 538.40 | 2032.00 | - | - | |
| PB Ratio | 3.51 | 2.52 | 2.69 | 1.60 | - | - | |
| P/TBV Ratio | 5.97 | 2.52 | 2.69 | 1.60 | - | - | |
| Debt / Equity Ratio | 0.09 | 0.27 | - | - | -0.61 | -0.84 | |
| Quick Ratio | 0.82 | 0.79 | 1.15 | 8.22 | 2.05 | 3.25 | |
| Current Ratio | 1.58 | 1.28 | 1.70 | 8.97 | 2.05 | 3.25 | |
| Return on Equity (ROE) | -490.03% | -759.85% | -148.57% | -80.53% | - | - | |
| Return on Assets (ROA) | -129.28% | -190.26% | -76.30% | -32.05% | -72.09% | -136.26% | |
| Return on Capital (ROIC) | -267.73% | -455.23% | -98.51% | -40.29% | - | - | |
| Earnings Yield | -257.15% | -448.40% | -201.12% | -20.91% | - | - | |
| FCF Yield | -273.47% | -437.86% | -181.64% | -16.87% | - | - | |
| Buyback Yield / Dilution | -18942.25% | -1003.48% | -54.03% | - | - | - | |
| Total Shareholder Return | -18942.25% | -1003.48% | -54.03% | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.